These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 871348)

  • 41. [Clinical aspects and diagnosis of chronic viral hepatitis B].
    Grigor'ev PIa; Iakovenko EP; Zakharov VN; Saiapina ES; Shubina GI
    Klin Med (Mosk); 1984 Feb; 62(2):5-10. PubMed ID: 6708442
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up.
    Yoshida FT; Takahashi C; Mercadante LA; Camargo IF; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):11-6. PubMed ID: 2975824
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hepatitis B virus infections in hospitals].
    Wirsing von König CH; Pohle D; Finger H
    Immun Infekt; 1984 Jun; 12(3):151-5. PubMed ID: 6534845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B program for health care personnel. Education, serologic surveillance, immunization.
    Kwapien CA; Phillips DA; Anderson LA
    AAOHN J; 1987 Jan; 35(1):19-23. PubMed ID: 2947584
    [No Abstract]   [Full Text] [Related]  

  • 45. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prevention of hepatitis B in the surgical clinic].
    Shalimov SA; Frolov AF; Radzikhovskiĭ AP; Orgel' MIa; Martsinkovskiĭ LT; Pokrasen NM; Shevchenko LF; Anan'ev VA; Tat'ianko NV
    Vestn Khir Im I I Grek; 1987 Jun; 138(6):133-6. PubMed ID: 3672774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Spread of infection due to the hepatitis B virus in the dental environment].
    Battagliese G; Guadagnino V; Borgia G; Sammartino G; Nappa S; Bianco S; Picciotto FP; Manzillo E; Matarasso S
    Minerva Stomatol; 1986 Dec; 35(12):1147-50. PubMed ID: 3469498
    [No Abstract]   [Full Text] [Related]  

  • 50. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active hepatitis B immunization with an experimental German vaccine. IV. Reactogenicity studies in healthy adults and in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):456-65. PubMed ID: 6485640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The importance of hepatitis B prophylaxis in health care workers.
    Kelkitli E; Yilmaz B; Karaoğlanoğlu M; Turgut M
    Turk J Gastroenterol; 2006 Sep; 17(3):244-5. PubMed ID: 16941267
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of active immunization against viral hepatitis B in patients on hemodialysis at the National Institute of Health for the Uranium Industry in Príbram].
    Benes R; Stipl Z; Halvová D; Simotová J
    Cas Lek Cesk; 1991 Mar; 130(9):269-71. PubMed ID: 2025902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unit.
    Nivet H; Drucker J; Dubois F; Goudeau A; Coursaget P; Rolland JC; Grenier B; Maupas P
    Int J Pediatr Nephrol; 1982 Mar; 3(1):25-8. PubMed ID: 7107116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B surface antigen (HbsAg): (a survey of hospital staff in Zambia).
    Bhagwat GP; Parmar S
    Med J Zambia; 1983 Oct; 17(4):106-8. PubMed ID: 6680555
    [No Abstract]   [Full Text] [Related]  

  • 58. Pattern of hepatitis B antigen--contact and carrier state in Northern India.
    Mital VN; Gupta OP; Nigam DK; Saxena PC; Kumar S
    J Indian Med Assoc; 1980 Mar; 74(6):105-7. PubMed ID: 7410864
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis B prevention. Part 1: A review of ACIP's newest guidelines.
    Valenti WM
    Infect Control; 1986 Feb; 7(2):74-7. PubMed ID: 2937752
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibody response to hepatitis B vaccine in medical & paramedical personnel in India.
    Sehgal A; Pavri K; Arankalle V; Jhala CI; Dhorje SP; Ramamoorthy CL
    Indian J Med Res; 1987 Mar; 85():231-4. PubMed ID: 2956189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.